MGX insider buying and SEC filings, explained
Metagenomi, Inc. · CIK 1785279
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$23K
Insiders who bought
1
Sold (not marked 10b5-1)
$44K
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Sep 9, 2026 | Purchase (code P) | Laurence Reid (Director) bought 20,000 shares at about $1.17 ($23K), reported as a purchase (code P). New position of 20,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 11, 2026 |
| Sep 8, 2026 | Sale | Matthew Wein (Officer) sold 358 shares at $1.16 ($415). Holdings down <1% to 126,133 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 10, 2026 |
| Sep 8, 2026 | Sale | Jian Irish (CEO and Director) sold 2,140 shares at $1.16 ($2K). Holdings down 1% to 375,393 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 10, 2026 |
| Sep 8, 2026 | Sale | Pamela Wapnick (CFO) sold 1,911 shares at $1.16 ($2K). Holdings down 1% to 206,580 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 10, 2026 |
| Jun 5, 2026 | Sale | Pamela Wapnick (CFO) sold 2,884 shares at $1.30 ($4K). Holdings down 1% to 208,491 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 10, 2026 |
| Jun 5, 2026 | Sale | Jian Irish (CEO and Director) sold 3,737 shares at $1.30 ($5K). Holdings down 1% to 377,533 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 10, 2026 |
| Jun 5, 2026 | Sale | Matthew Wein (Officer) sold 558 shares at $1.30 ($725). Holdings down <1% to 126,491 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 10, 2026 |
| Mar 5, 2026 | Sale | Pamela Wapnick (CFO) sold 1,581 shares at $1.60 ($3K). Holdings down 1% to 187,375 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 9, 2026 |
| Mar 5, 2026 | Sale | Matthew Wein (Officer) sold 482 shares at $1.60 ($771). Holdings down <1% to 114,549 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 9, 2026 |
| Mar 5, 2026 | Sale | Jian Irish (CEO and Director) sold 1,607 shares at $1.60 ($3K). Holdings down <1% to 333,770 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 9, 2026 |
| Dec 5, 2025 | Sale | Brian C. Thomas (Director) sold 3,830 shares at $1.77 ($7K). Holdings down <1% to 2,510,960 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 8, 2025 |
| Dec 5, 2025 | Sale | Matthew Wein (Officer) sold 199 shares at $1.77 ($352). Holdings down <1% to 115,031 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 8, 2025 |
| Dec 5, 2025 | Sale | Pamela Wapnick (CFO) sold 1,576 shares at $1.77 ($3K). Holdings down 1% to 188,956 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 8, 2025 |
| Dec 5, 2025 | Sale | Jian Irish (CEO and Director) sold 1,602 shares at $1.77 ($3K). Holdings down <1% to 563,839 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 8, 2025 |
| Sep 5, 2025 | Sale | Brian C. Thomas (Director) sold 2,701 shares at $1.81 ($5K). Holdings down <1% to 2,514,790 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 1, 2025 |
| Sep 5, 2025 | Sale | Pamela Wapnick (CFO) sold 1,576 shares at $1.81 ($3K). Holdings down 2% to 70,532 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 1, 2025 |
| Sep 5, 2025 | Sale | Jian Irish (CEO and Director) sold 1,602 shares at $1.81 ($3K). Holdings down 1% to 316,941 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 1, 2025 |
| Sep 5, 2025 | Sale | Matthew Wein (Officer) sold 199 shares at $1.81 ($360). Holdings down 1% to 19,230 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 1, 2025 |
11 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow MGX in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.